Your session is about to expire
← Back to Search
Behavioral Intervention
Culturally tailored diabetes program for Diabetes (Namaste Trial)
N/A
Waitlist Available
Led By Nadia A Khan, MD MSc
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months; 0, 3, and 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether a culturally tailored intervention can improve diabetes outcomes in South Asian patients.
Eligible Conditions
- Diabetes
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months; 0, 3, and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months; 0, 3, and 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Other study objectives
Procedure related outcomes
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Culturally tailored diabetes programExperimental Treatment1 Intervention
Culturally tailored diabetes program
* culturally tailored diabetes education
* lifestyle counselling
* medication adherence counseling
* peer supporter
* communication training
* family member involvement
Group II: Usual CareActive Control1 Intervention
Usual Care includes continuing to visit primary care physician for ongoing diabetes management Printed diabetes education materials.
Find a Location
Who is running the clinical trial?
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,386 Previous Clinical Trials
26,515,375 Total Patients Enrolled
25 Trials studying Diabetes
2,228 Patients Enrolled for Diabetes
University of British ColumbiaLead Sponsor
1,465 Previous Clinical Trials
2,484,897 Total Patients Enrolled
10 Trials studying Diabetes
363 Patients Enrolled for Diabetes
Nadia A Khan, MD MScPrincipal InvestigatorUniversity of British Columbia
Share this study with friends
Copy Link
Messenger